• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

IA 期肺腺癌中高级别模式比例与复发的显著差异。

Significant difference in recurrence according to the proportion of high grade patterns in stage IA lung adenocarcinoma.

机构信息

Department of Thoracic and Cardiovascular Surgery, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.

Department of Thoracic and Cardiovascular Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.

出版信息

Thorac Cancer. 2021 Jul;12(13):1952-1958. doi: 10.1111/1759-7714.13984. Epub 2021 May 25.

DOI:10.1111/1759-7714.13984
PMID:34037324
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8258359/
Abstract

BACKGROUND

Patients with early lung cancer are the best candidates for surgical resection. However, those patients with high grade patterns (micropapillary or solid) do not have a good prognosis, even if they have been diagnosed with stage I lung adenocarcinoma. A new modified grading system has been introduced and this study aimed to identify the prognostic role of the new grading system in patients with stage IA lung adenocarcinoma.

METHODS

Patients with pathological stage IA lung adenocarcinoma, according to the eighth TNM classification who underwent curative resection, were reviewed. The pathological data of stage IA adenocarcinoma was reviewed 1 (grade 1: lepidic predominant with no or less than 20% of high grade patterns, grade 2: acinar or papillary predominant with no or less than 20% of high grade patterns, grade 3: any tumor with 20% or more of high grade patterns). Prognostic factors were analyzed for disease-free interval (DFI) and overall survival (OS) using Cox proportional models.

RESULTS

The medical records of 429 patients with stage IA lung adenocarcinoma were reviewed. DFI (p < 0.001) and OS (p < 0.001) were significantly lower in patients diagnosed with grade 3 compared with grade 1 and grade 2. Multivariate analysis showed that smoking (p = 0.013), value of SUVmax (p = 0.005), lymphovascular invasion (p = 0.004) and grade 3 (p = 0.008) were significant prognostic factors for DFI.

CONCLUSIONS

The proportion of high grade patterns showed a different prognosis, even if curative resection had been performed for stage IA adenocarcinoma. This new grading system is more simple and useful in the prediction of a prognosis in patients with stage IA lung adenocarcinoma.

摘要

背景

早期肺癌患者是手术切除的最佳人选。然而,那些具有高级别模式(微乳头状或实体状)的患者预后不佳,即使他们被诊断为 I 期肺腺癌。已经引入了一种新的改良分级系统,本研究旨在确定新分级系统在 I 期肺腺癌患者中的预后作用。

方法

回顾了根据第八版 TNM 分类接受根治性切除的病理分期为 IA 期肺腺癌患者。回顾了 IA 期腺癌的病理数据,分为 1 级(贴壁为主,高级别模式比例小于等于 20%)、2 级(腺泡或乳头为主,高级别模式比例小于等于 20%)、3 级(任何肿瘤高级别模式比例大于 20%)。使用 Cox 比例模型分析无病间隔(DFI)和总生存(OS)的预后因素。

结果

回顾了 429 例 IA 期肺腺癌患者的病历。DFI(p<0.001)和 OS(p<0.001)在 3 级患者中明显低于 1 级和 2 级患者。多变量分析显示,吸烟(p=0.013)、SUVmax 值(p=0.005)、血管淋巴管侵犯(p=0.004)和 3 级(p=0.008)是 DFI 的显著预后因素。

结论

即使对 IA 期腺癌进行了根治性切除,高级别模式的比例也显示出不同的预后。这种新的分级系统在预测 IA 期肺腺癌患者的预后方面更加简单和有效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/332c/8258359/05aa4a57c396/TCA-12-1952-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/332c/8258359/0da30c4072c1/TCA-12-1952-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/332c/8258359/05aa4a57c396/TCA-12-1952-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/332c/8258359/0da30c4072c1/TCA-12-1952-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/332c/8258359/05aa4a57c396/TCA-12-1952-g002.jpg

相似文献

1
Significant difference in recurrence according to the proportion of high grade patterns in stage IA lung adenocarcinoma.IA 期肺腺癌中高级别模式比例与复发的显著差异。
Thorac Cancer. 2021 Jul;12(13):1952-1958. doi: 10.1111/1759-7714.13984. Epub 2021 May 25.
2
Prognostic impact according to the proportion of the lepidic subtype in stage IA acinar-predominant lung adenocarcinoma.根据 I 期以腺泡为主型肺腺癌中鳞屑型亚型的比例进行预后评估。
Thorac Cancer. 2021 Jul;12(14):2072-2077. doi: 10.1111/1759-7714.14013. Epub 2021 May 25.
3
Does the histologic predominance of pathological stage IA lung adenocarcinoma influence the extent of resection?病理分期为IA期的肺腺癌的组织学优势是否会影响切除范围?
Gen Thorac Cardiovasc Surg. 2017 Sep;65(9):512-518. doi: 10.1007/s11748-017-0790-0. Epub 2017 Jun 7.
4
Prognostic value of the new IASLC/ATS/ERS classification of clinical stage IA lung adenocarcinoma.IASLC/ATS/ERS 新肺腺癌临床分期 IA 分类的预后价值。
Lung Cancer. 2015 Nov;90(2):199-204. doi: 10.1016/j.lungcan.2015.06.022. Epub 2015 Jul 2.
5
Integrating IASLC grading and radiomics for predicting postoperative outcomes in stage IA invasive lung adenocarcinoma.IASLC 分级与放射组学相结合预测 IA 期浸润性肺腺癌术后结局。
Med Phys. 2024 Sep;51(9):6513-6524. doi: 10.1002/mp.17177. Epub 2024 May 23.
6
A prognostic nomogram based on a new classification of combined micropapillary and solid components for stage IA invasive lung adenocarcinoma.基于IA期浸润性肺腺癌微乳头和实性成分新分类的预后列线图。
J Surg Oncol. 2022 Mar;125(4):796-808. doi: 10.1002/jso.26760. Epub 2021 Dec 3.
7
[Validation of prognostic value of pathological staging in pathological stage Ⅰ lung adenocarcinoma].[Ⅰ期肺腺癌病理分期预后价值的验证]
Zhonghua Wai Ke Za Zhi. 2022 Jun 1;60(6):580-586. doi: 10.3760/cma.j.cn112139-20211008-00474.
8
Prognostic significance and adjuvant chemotherapy survival benefits of a solid or micropapillary pattern in patients with resected stage IB lung adenocarcinoma.切除的ⅠB 期肺腺癌中实性或微乳头状模式的预后意义和辅助化疗生存获益。
J Thorac Cardiovasc Surg. 2018 Mar;155(3):1227-1235.e2. doi: 10.1016/j.jtcvs.2017.09.143. Epub 2017 Nov 7.
9
Impact of Nodule Density in Women With Sublobar Resection for Stage IA Adenocarcinoma.亚肺叶切除治疗Ⅰ A 期腺癌时结节密度对女性的影响。
Ann Thorac Surg. 2021 Oct;112(4):1067-1075. doi: 10.1016/j.athoracsur.2020.10.022. Epub 2020 Nov 9.
10
Prognostic value of the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society lung adenocarcinoma classification on death and recurrence in completely resected stage I lung adenocarcinoma.新国际肺癌研究协会/美国胸科学会/欧洲呼吸学会肺腺癌分类对完全切除的 I 期肺腺癌患者死亡和复发的预后价值。
Ann Surg. 2013 Dec;258(6):1079-86. doi: 10.1097/SLA.0b013e31828920c0.

引用本文的文献

1
Machine learning algorithms for predicting malignancy grades of lung adenocarcinoma and guiding treatments: CT radiomics-based comparisons.用于预测肺腺癌恶性程度和指导治疗的机器学习算法:基于CT影像组学的比较
J Thorac Dis. 2025 Apr 30;17(4):2423-2440. doi: 10.21037/jtd-2025-310. Epub 2025 Apr 28.
2
Preoperative CT-based Radiomics Model for Predicting Micropapillary/Solid Patterns in Stage I Peripheral Lung Invasive Adenocarcinoma: A Propensity Score Matching Study.基于术前CT的放射组学模型预测Ⅰ期周围型肺浸润性腺癌微乳头/实性模式:一项倾向评分匹配研究
J Thorac Imaging. 2025 Jul 1;40(4):e0826. doi: 10.1097/RTI.0000000000000826.
3

本文引用的文献

1
A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology Committee.侵袭性肺腺癌分级系统:国际肺癌研究协会病理学委员会的建议。
J Thorac Oncol. 2020 Oct;15(10):1599-1610. doi: 10.1016/j.jtho.2020.06.001. Epub 2020 Jun 17.
2
Cancer statistics, 2019.癌症统计数据,2019 年。
CA Cancer J Clin. 2019 Jan;69(1):7-34. doi: 10.3322/caac.21551. Epub 2019 Jan 8.
3
Causes of death in long-term survivors of non-small cell lung cancer: A regional Surveillance, Epidemiology, and End Results study.
Application and progress of non-invasive imaging in predicting lung invasive non-mucinous adenocarcinoma under the new IASLC grading guidelines.
非侵入性成像在新国际肺癌研究协会(IASLC)分级指南下预测肺浸润性非黏液腺癌中的应用与进展
Insights Imaging. 2025 Jan 2;16(1):4. doi: 10.1186/s13244-024-01877-4.
4
Prognostic significance using histologic subtype in stage I lung adenocarcinoma.组织学亚型在Ⅰ期肺腺癌中的预后意义。
J Thorac Dis. 2024 Oct 31;16(10):6760-6769. doi: 10.21037/jtd-24-905. Epub 2024 Oct 30.
5
Prognostic impact of the newly revised IASLC proposed grading system for invasive lung adenocarcinoma: a systematic review and meta-analysis.新修订的 IASLC 提出的浸润性肺腺癌分级系统对预后的影响:系统评价和荟萃分析。
World J Surg Oncol. 2024 Nov 14;22(1):302. doi: 10.1186/s12957-024-03584-2.
6
Predicting prognosis in patients with stage IA lung adenocarcinoma with a micropapillary component using a nomogram based on computed tomography radiomics and clinicopathologic factors: a retrospective analysis.基于计算机断层扫描影像组学和临床病理因素的列线图预测伴有微乳头成分的IA期肺腺癌患者的预后:一项回顾性分析
Transl Lung Cancer Res. 2024 Oct 31;13(10):2585-2602. doi: 10.21037/tlcr-24-544. Epub 2024 Oct 28.
7
Predicting pathological grade of stage I pulmonary adenocarcinoma: a CT radiomics approach.预测Ⅰ期肺腺癌的病理分级:一种CT影像组学方法。
Front Oncol. 2024 Sep 27;14:1406166. doi: 10.3389/fonc.2024.1406166. eCollection 2024.
8
Significance of histologic subtype size as a prognostic indicator in stage IA lung adenocarcinoma.组织学亚型大小作为ⅠA期肺腺癌预后指标的意义
J Thorac Dis. 2023 Oct 31;15(10):5405-5413. doi: 10.21037/jtd-23-913. Epub 2023 Sep 28.
9
Establishment and validation of nomograms for predicting survival of lung invasive adenocarcinoma based on the level of pathological differentiation: a SEER cohort-based analysis.基于病理分化程度预测肺浸润性腺癌生存的列线图的建立与验证:一项基于监测、流行病学和最终结果(SEER)队列的分析
Transl Cancer Res. 2023 Apr 28;12(4):804-827. doi: 10.21037/tcr-22-2308. Epub 2023 Apr 7.
10
Prediction of high-grade patterns of stage IA lung invasive adenocarcinoma based on high-resolution CT features: a bicentric study.基于高分辨率 CT 特征预测 IA 期肺浸润性腺癌的高级别模式:一项双中心研究。
Eur Radiol. 2023 Jun;33(6):3931-3940. doi: 10.1007/s00330-022-09379-x. Epub 2023 Jan 4.
非小细胞肺癌长期幸存者的死因:一项地区性监测、流行病学和最终结果研究。
Ann Thorac Med. 2018 Apr-Jun;13(2):76-81. doi: 10.4103/atm.ATM_243_17.
4
Lymph node involvement according to lung adenocarcinoma subtypes: lymph node involvement is influenced by lung adenocarcinoma subtypes.根据肺腺癌亚型的淋巴结受累情况:淋巴结受累受肺腺癌亚型影响。
J Thorac Dis. 2017 Oct;9(10):3903-3910. doi: 10.21037/jtd.2017.08.132.
5
Impact of Solid Minor Histologic Subtype in Postsurgical Prognosis of Stage I Lung Adenocarcinoma.实性微小组织学亚型对Ⅰ期肺腺癌术后预后的影响
Ann Thorac Surg. 2018 Jan;105(1):302-308. doi: 10.1016/j.athoracsur.2017.08.018. Epub 2017 Nov 20.
6
Genetic and Immune Profiles of Solid Predominant Lung Adenocarcinoma Reveal Potential Immunotherapeutic Strategies.实性为主型肺腺癌的遗传和免疫特征揭示了潜在的免疫治疗策略。
J Thorac Oncol. 2018 Jan;13(1):85-96. doi: 10.1016/j.jtho.2017.10.020. Epub 2017 Nov 7.
7
Histological features of malignancy correlate with growth patterns and patient outcome in lung adenocarcinoma.肺腺癌中恶性肿瘤的组织学特征与生长模式和患者预后相关。
Histopathology. 2017 Sep;71(3):425-436. doi: 10.1111/his.13236. Epub 2017 Jun 16.
8
ALK rearrangement in specific subtypes of lung adenocarcinoma: immunophenotypic and morphological features.肺腺癌特定亚型中的ALK重排:免疫表型和形态学特征
Med Oncol. 2017 May;34(5):76. doi: 10.1007/s12032-017-0936-z. Epub 2017 Mar 31.
9
The Clinical Impact of Solid and Micropapillary Patterns in Resected Lung Adenocarcinoma.切除肺腺癌中实性和微乳头模式的临床影响。
J Thorac Oncol. 2016 Nov;11(11):1976-1983. doi: 10.1016/j.jtho.2016.06.014. Epub 2016 Jun 30.
10
Lymph node involvement influenced by lung adenocarcinoma subtypes in tumor size ≤3 cm disease: A study of 2268 cases.肿瘤大小≤3cm的疾病中肺腺癌亚型对淋巴结受累的影响:一项对2268例病例的研究。
Eur J Surg Oncol. 2016 Nov;42(11):1714-1719. doi: 10.1016/j.ejso.2016.02.247. Epub 2016 Mar 8.